Your browser doesn't support javascript.
loading
Visual associative learning to detect early episodic memory deficits and distinguish Alzheimer's disease from other types of dementia.
Dubbelman, Mark A; Tomassen, Jori; van der Landen, Sophie M; Bakker, Els; Kamps, Suzie; van Unnik, Annemartijn A J M; van de Glind, Marie-Christine A B J; van der Vlies, Annelies E; Koene, Ted; Leeuwis, Anna E; Barkhof, Frederik; van Harten, Argonde C; Teunissen, Charlotte; van de Giessen, Elsmarieke; Lemstra, Afina W; Pijnenburg, Yolande A L; Ponds, Rudolf W H; Sikkes, Sietske A M.
Afiliación
  • Dubbelman MA; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Tomassen J; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • van der Landen SM; Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bakker E; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Kamps S; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • van Unnik AAJM; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • van de Glind MABJ; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • van der Vlies AE; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Koene T; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Leeuwis AE; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Barkhof F; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • van Harten AC; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Teunissen C; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • van de Giessen E; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Lemstra AW; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Pijnenburg YAL; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
  • Ponds RWH; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Sikkes SAM; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
J Int Neuropsychol Soc ; : 1-10, 2024 Feb 23.
Article en En | MEDLINE | ID: mdl-38389489
ABSTRACT

OBJECTIVE:

We investigated how well a visual associative learning task discriminates Alzheimer's disease (AD) dementia from other types of dementia and how it relates to AD pathology.

METHODS:

3,599 patients (63.9 ± 8.9 years old, 41% female) from the Amsterdam Dementia Cohort completed two sets of the Visual Association Test (VAT) in a single test session and underwent magnetic resonance imaging. We performed receiver operating curve analysis to investigate the VAT's discriminatory ability between AD dementia and other diagnoses and compared it to that of other episodic memory tests. We tested associations between VAT performance and medial temporal lobe atrophy (MTA), and amyloid status (n = 2,769, 77%).

RESULTS:

Patients with AD dementia performed worse on the VAT than all other patients. The VAT discriminated well between AD and other types of dementia (area under the curve range 0.70-0.86), better than other episodic memory tests. Six-hundred forty patients (17.8%) learned all associations on VAT-A, but not on VAT-B, and they were more likely to have higher MTA scores (odds ratios range 1.63 (MTA 0.5) through 5.13 for MTA ≥ 3, all p < .001) and to be amyloid positive (odds ratio = 3.38, 95%CI = [2.71, 4.22], p < .001) than patients who learned all associations on both sets.

CONCLUSIONS:

Performance on the VAT, especially on a second set administered immediately after the first, discriminates AD from other types of dementia and is associated with MTA and amyloid positivity. The VAT might be a useful, simple tool to assess early episodic memory deficits in the presence of AD pathology.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Int Neuropsychol Soc Asunto de la revista: NEUROLOGIA / PSICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Int Neuropsychol Soc Asunto de la revista: NEUROLOGIA / PSICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos